These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2487793

  • 1. [Etiopathogenesis of membranous nephropathy: is there a correlation between experimental and human pathology?].
    Allegri L, Celendo MT, Savazzi G, Garini G, Carnevali ML.
    Ann Ital Med Int; 1989; 4(4):386-95. PubMed ID: 2487793
    [Abstract] [Full Text] [Related]

  • 2. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G, Brentjens JR, Noble B, Kerjaschki D, Malavasi F, Roholt OA, Farquhar MG, Andres G.
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [Abstract] [Full Text] [Related]

  • 3. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A, Yuzawa Y, Olson L, Miller J, Milgrom M, Zamlauski-Tucker MJ, Van Liew JB, Campagnari A, Niesen N, Patel J.
    Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
    [Abstract] [Full Text] [Related]

  • 4. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ, Belok S, Stilmant MM, Darby C, Couser WG.
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M, Schulze M, Exner M, Kerjaschki D.
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [Abstract] [Full Text] [Related]

  • 6. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P, Allegri L, Brianti E, Chatelet F, Van Leer EH, Verroust P.
    Appl Pathol; 1989 Apr; 7(2):85-98. PubMed ID: 2567175
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G, Noble B, Van Liew J, Brentjens JR, Andres G.
    J Immunol; 1986 Mar 15; 136(6):2127-35. PubMed ID: 3485141
    [Abstract] [Full Text] [Related]

  • 8. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.
    Hori MT, Abrass CK.
    J Immunol; 1990 May 15; 144(10):3849-55. PubMed ID: 2185315
    [Abstract] [Full Text] [Related]

  • 9. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D.
    Verh Dtsch Ges Pathol; 1989 May 15; 73():24-35. PubMed ID: 2482609
    [Abstract] [Full Text] [Related]

  • 10. [Formation of immune deposits during experimental extramembranous glomerulonephritis].
    Verroust P, Ronco P.
    Nephrologie; 1989 May 15; 10(3):123-6. PubMed ID: 2691908
    [Abstract] [Full Text] [Related]

  • 11. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP, Tramontano A.
    J Pathol; 2006 Nov 15; 210(3):282-7. PubMed ID: 16981232
    [Abstract] [Full Text] [Related]

  • 12. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
    Camussi G, Salvidio G, Biesecker G, Brentjens J, Andres G.
    J Immunol; 1987 Nov 01; 139(9):2906-14. PubMed ID: 3312408
    [Abstract] [Full Text] [Related]

  • 13. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.
    Ronco P, Debiec H.
    J Am Soc Nephrol; 2005 May 01; 16(5):1205-13. PubMed ID: 15800120
    [Abstract] [Full Text] [Related]

  • 14. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
    Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG.
    J Immunol; 1989 Jul 15; 143(2):546-52. PubMed ID: 2738403
    [Abstract] [Full Text] [Related]

  • 15. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli.
    Leung CC, Cheewatrakoolpong B, O'Mara T, Black M.
    Am J Anat; 1987 Jun 15; 179(2):169-74. PubMed ID: 3303894
    [Abstract] [Full Text] [Related]

  • 16. [Molecular analysis of experimental membranous glomerulonephritis (Heymann nephritis)].
    Kerjaschki D.
    Verh Dtsch Ges Pathol; 1996 Jun 15; 80():139-47. PubMed ID: 9064996
    [Abstract] [Full Text] [Related]

  • 17. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
    Cybulsky AV, Quigg RJ, Salant DJ.
    J Immunol; 1986 Sep 01; 137(5):1511-6. PubMed ID: 3745914
    [Abstract] [Full Text] [Related]

  • 18. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T, Remuzzi G, Poggi A, Delaini F, Sacchi G, Morassi L, Verroust P, Mecca G, Donati MB.
    Clin Exp Immunol; 1983 Jan 01; 51(1):38-44. PubMed ID: 6339125
    [Abstract] [Full Text] [Related]

  • 19. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y, Hayakawa I, Shibata S.
    Lab Invest; 1986 Jul 01; 55(1):63-70. PubMed ID: 3755192
    [Abstract] [Full Text] [Related]

  • 20. The immunopathogenesis of membranous nephropathy.
    Oliveira DB.
    Minerva Med; 2002 Oct 01; 93(5):323-8. PubMed ID: 12410164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.